Noah Schoenholtz

High-Priced Drug Could Be Deal Changer

Sovaldi, a drug for treating hepatitis C, has the potential to be a canary in the coal mine of drug policy. Government officials, insurance companies and consumers in many countries are grappling with the problem of how to pay for the effective but costly medication.

Rate Regulation Battle Lines Drawn

Strategies are taking shape in the battle over a ballot initiative to give California officials regulatory authority over health insurance rate increases. Two days after proponents staged a rally denouncing huge cash reserves held by Kaiser Permanente, opponents released a study finding that such regulation could throw a wrench in reform efforts.